Collage of CBMM pictures

Funded by The National Institute of Biomedical Imaging and Bioengineering

We design, manufacture, and deliver new tools to the biomedical community that utilize liquid biopsies for disease detection and management.

Our Vision & Mission




What is Precision Medicine?

The "Precision Medicine" initiative was announced by President Obama in his 2016 State of the Union address.

The initiative aims to shift away from a generic treatment approach to customizing medications for individuals. This tailored approach ensures that patients receive the most effective and safe treatments by targeting the specific characteristics of their illness. 

CBM2 is contributing to the Precision Medicine initiative by developing advanced tools that can rapidly deliver crucial diagnostic and prognostic information, overcoming current testing limitations.

As President Obama envisioned, this initiative strives to deliver "the right treatment at the right time."

 

Metal compasses hover over a DNA model with red and blue spheres atop a grey cylindrical base.
Student giving tour in white lab suits

Plastics Engineering

Design and fabricate microfluidic and nanofluidic devices in thermoplastics.​

Learn about plastics engineering
A magnified view showcasing a textured spherical cell surrounded by smooth red blood cells.

Liquid Biopsy Analysis

Highly efficient isolation and molecular analysis (CTCs, EVs, cfDNA).

Learn about liquid biopsy analysis

CBM² Stories

Soper Lab and CBM2 Members Publish New Research in the Royal Society of Chemistry Journal

Members of the Soper lab and CBM² have published a new article in the Royal Society of Chemistry's journal, Lab on a Chip.

Three New Articles from Prof. Godwin Published in the Journal of Clinical Oncology

Prof. Andrew Godwin, PhD had three new articles published in the Journal of Clinical Oncology this month in a series of investigations related to breast cancer treatment.

Student with Sunggook Park's Group Honored as Distinguished Undergraduate Researcher

LSU Student Corinne Martin was honored at the Distinguished Undergraduate Researcher ceremony for her work with CMB²'s Dr. Sunggook Park. Martin's qualifying project was titled "Nanoscale Control over the Pore Size for PEGDA In-Plane Nanopore Devices by a Pressure Jig."

CBM2's Webinar Draws 99 Enthusiastic Participants

Following the insightful webinar on "Liquid Gold in Precision Medicine: Liquid-Based Biopsies for Cancer Detection and Monitoring," hosted by the Center of BioModular Multi-Scale Systems for Precision Medicine (CBM2), the ripple effect of knowledge spread far and wide.

Upcoming Events

Organization Statistics

5
Partnering Organizations
4
Supporting Universities
40+
Researchers
Neon-colored interconnected bio-structures in elongated hexagonal patterns. Representing BioModular Multi-Scale Systems for Precision Medicine

Work with us

The Center is excited to accept requests for collaboration projects with researchers in the biomedical and microfluidics community.

Collaboration & Service Projects